The historical rank and industry rank for Cowealth Medical Holding Co's FCF Margin % or its related term are showing as below:
ROCO:4745'
s FCF Margin % Range Over the Past 10 Years
Min: -5.22 Med: 0.94 Max: 16.45
Current: 0.03
During the past 13 years, the highest FCF Margin % of Cowealth Medical Holding Co was 16.45%. The lowest was -5.22%. And the median was 0.94%.
ROCO:4745's FCF Margin % is ranked better than 50.74% of 816
companies
in the Medical Devices & Instruments industry
Industry Median: -0.55
vs ROCO:4745: 0.03
Cowealth Medical Holding Co FCF Margin % Related Terms
Cowealth Medical Holding Co FCF Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:4745 vs ABT, SYK, MDT: FCF Margin % Comparison
For the Medical Devices subindustry, Cowealth Medical Holding Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cowealth Medical Holding Co FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Cowealth Medical Holding Co's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Cowealth Medical Holding Co's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cowealth Medical Holding Co (ROCO:4745) has a FCF Margin % of -85.02% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Cowealth Medical Holding Co and its competitors. According to the industry distribution chart, Cowealth Medical Holding Co ranks #402 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 49.3%.
Is Cowealth Medical Holding Co's FCF Margin % too high?
Cowealth Medical Holding Co's current FCF Margin % is -85.02%. Based on the distribution chart, Cowealth Medical Holding Co ranks #402 out of 816 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Cowealth Medical Holding Co has a GF Score™ of 50/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Cowealth Medical Holding Co's FCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Cowealth Medical Holding Co ranks #402 out of 816 companies for FCF Margin %. This puts Cowealth Medical Holding Co in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Cowealth Medical Holding Co and its competitors. Cowealth Medical Holding Co's current FCF Margin % is -85.02%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cowealth Medical Holding Co stock overvalued right now?
Based on GuruFocus' analysis, Cowealth Medical Holding Co (ROCO:4745) is currently considered Fairly Valued. The stock's GF Value™ is NT$13.11, compared to a current price of NT$13.80 — trading 5.3% above its estimated fair value. The current FCF Margin % is -85.02%. Cowealth Medical Holding Co's overall GF Score™ is 50/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Cowealth Medical Holding Co (ROCO:4745), the current FCF Margin % is -85.02% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cowealth Medical Holding Co (ROCO:4745) Overvalued in 2026?
Based on GuruFocus' analysis, Cowealth Medical Holding Co stock appears to be overvalued.
The current stock price of NT$13.80 is trading 5.3% above its estimated GF Value™ of NT$13.11.
GuruFocus considers Cowealth Medical Holding Co to be Fairly Valued.
Key valuation signals for ROCO:4745:
FCF Margin %: -85.02%
GF Value™: NT$13.11 vs. price of NT$13.80 (5.3% above fair value)
No single metric tells the full story. See the ROCO:4745 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cowealth Medical Holding Co Ltd is mainly involved in trading medical equipment, reagents, and spare parts. Its wide range of solutions includes refined management services tailored for in-vitro diagnostic products, reagents, and consumables, an integrated platform designed for decision-making and analysis, commercialization of achievements in medical science and technology, a Multi-Channel Coaxial Time Audio Video Imaging Platform (MCCTAVIP), and an AI-assisted system for clinical diagnosis. The Group has two reportable segments: Segment A, which generates maximum revenue and sells equipment, and Segment B, which sells reagents and others. Geographically, it generates maximum revenue from China and Hong Kong, and the rest from Taiwan.
50GF Score
Get the complete analysis for ROCO:4745
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4745 has been successfully added to your 
